High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS)

Abstract C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are available on high-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of PCOS especially in Indian women....

Full description

Saved in:
Bibliographic Details
Published inGynecological endocrinology Vol. 30; no. 11; pp. 781 - 784
Main Authors Ganie, Mohd Ashraf, Hassan, Saqib, Nisar, Sobia, Shamas, Nasir, Rashid, Aafia, Ahmed, Ishfaq, Douhat, Syed, Mudassar, Syed, Jan, Vicar M., Rashid, Fouzia
Format Journal Article
LanguageEnglish
Published England Informa UK Ltd 01.11.2014
Taylor & Francis
Subjects
Online AccessGet full text
ISSN0951-3590
1473-0766
1473-0766
DOI10.3109/09513590.2014.924099

Cover

Abstract Abstract C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are available on high-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of PCOS especially in Indian women. The objective was to determine serum hs-CRP concentration in adolescent women with and without PCOS and to assess possible correlations of serum hs-CRP levels with components of PCOS in Indian women. One hundred and sixty women with PCOS and sixty non-PCOS women having normal menstrual cycles were included. Clinical assessment included anthropometry, Ferriman-Gallwey (FG) score and blood pressure (BP) measurement. Laboratory evaluation included estimation of T4, TSH, LH, FSH, total testosterone, prolactin, cortisol, 17OHP, hs-CRP, lipid profile, and insulin, and glucose after 2-h oral glucose tolerance test. Homeostasis Model Assessment Insulin resistance index (HOMA-IR) and Quantitative Insulin Sensitivity Check Index (QUICKI) and glucose intolerance was calculated. FG score, LH, FSH, total Testosterone, HOMA-IR and QUICKI were significantly different among women with or without PCOS (p < 0.01). Although hs-CRP levels showed a higher trend in women having PCOS, there was no significant difference between the groups (p > 0.05). A significant and positive correlation was found between hs-CRP and body mass index (BMI) (r = 0.308, p < 0.01) among PCOS group. The results in Indian adolescent women suggest that hs-CRP levels may not per se be associated with PCOS, rather can be related to fat mass in this subset of subjects. Chinese abstract C反应蛋白(CRP)是2型糖尿病和心血管疾病的危险因素。对于多囊卵巢综合征(PCOS),尤其是印度女性,在高敏C反应蛋白(hs-CRP)水平及其与PCOS的各项组分的关系方面,可查到的数据很有限。本研究的目的是监测患或不患PCOS的青春期女性的血清hs-CRP浓度,评估印度女性的血清hs-CRP浓度与PCOS指标间可能的相关性。160名PCOS患者和60名有正常月经周期的非PCOS女性参与了本试验。临床评价包括人体测量,Ferriman-Gallwey(FG)评分和血压(BP)测量。实验室测定指标包括T4,TSH, LH,,FSH,总睾酮,催乳素,皮质醇,17-OHP,hs-CRP,血脂,胰岛素的测量和2h口服葡萄糖耐量试验。同时测量稳态模式评估胰岛素抵抗指数(HOMA-IR),定量胰岛素敏感性检测指数(QUICKI)以及葡萄糖耐量。PCOS患者与正常女性的FG得分,LH,,FSH,HOMA-IR,QUICKI存在显著不同(p<0.01),尽管PCOS患者的hs-CRP水平有增高的趋势,但两组并无显著差别(p>0.05)。在PCOS组还发现hs-CRP与体重指数(BMI)有显著正相关(r=0.308, p<0.01)。该结果表明,hs-CRP水平与PCOS也许无关联性,而可能与该课题中的子项目即体重相关。
AbstractList C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are available on high-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of PCOS especially in Indian women. The objective was to determine serum hs-CRP concentration in adolescent women with and without PCOS and to assess possible correlations of serum hs-CRP levels with components of PCOS in Indian women. One hundred and sixty women with PCOS and sixty non-PCOS women having normal menstrual cycles were included. Clinical assessment included anthropometry, Ferriman-Gallwey (FG) score and blood pressure (BP) measurement. Laboratory evaluation included estimation of T4, TSH, LH, FSH, total testosterone, prolactin, cortisol, 17OHP, hs-CRP, lipid profile, and insulin, and glucose after 2-h oral glucose tolerance test. Homeostasis Model Assessment Insulin resistance index (HOMA-IR) and Quantitative Insulin Sensitivity Check Index (QUICKI) and glucose intolerance was calculated. FG score, LH, FSH, total Testosterone, HOMA-IR and QUICKI were significantly different among women with or without PCOS (p < 0.01). Although hs-CRP levels showed a higher trend in women having PCOS, there was no significant difference between the groups (p > 0.05). A significant and positive correlation was found between hs-CRP and body mass index (BMI) (r = 0.308, p < 0.01) among PCOS group. The results in Indian adolescent women suggest that hs-CRP levels may not per se be associated with PCOS, rather can be related to fat mass in this subset of subjects. C反应蛋白(CRP)是2型糖尿病和心血管疾病的危险因素。对于多囊卵巢综合征(PCOS),尤其是印度女性,在高敏C反应蛋白(hs-CRP)水平及其与PCOS的各项组分的关系方面,可查到的数据很有限。本研究的目的是监测患或不患PCOS的青春期女性的血清hs-CRP浓度,评估印度女性的血清hs-CRP浓度与PCOS指标间可能的相关性。160名PCOS患者和60名有正常月经周期的非PCOS女性参与了本试验。临床评价包括人体测量,Ferriman-Gallwey(FG)评分和血压(BP)测量。实验室测定指标包括T4,TSH, LH,,FSH,总睾酮,催乳素,皮质醇,17-OHP,hs-CRP,血脂,胰岛素的测量和2h口服葡萄糖耐量试验。同时测量稳态模式评估胰岛素抵抗指数(HOMA-IR),定量胰岛素敏感性检测指数(QUICKI)以及葡萄糖耐量。PCOS患者与正常女性的FG得分,LH,,FSH,HOMA-IR,QUICKI存在显著不同(p<0.01),尽管PCOS患者的hs-CRP水平有增高的趋势,但两组并无显著差别(p>0.05)。在PCOS组还发现hs-CRP与体重指数(BMI)有显著正相关(r=0.308, p<0.01)。该结果表明,hs-CRP水平与PCOS也许无关联性,而可能与该课题中的子项目即体重相关。
C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are available on high-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of PCOS especially in Indian women. The objective was to determine serum hs-CRP concentration in adolescent women with and without PCOS and to assess possible correlations of serum hs-CRP levels with components of PCOS in Indian women. One hundred and sixty women with PCOS and sixty non-PCOS women having normal menstrual cycles were included. Clinical assessment included anthropometry, Ferriman-Gallwey (FG) score and blood pressure (BP) measurement. Laboratory evaluation included estimation of T4, TSH, LH, FSH, total testosterone, prolactin, cortisol, 17OHP, hs-CRP, lipid profile, and insulin, and glucose after 2-h oral glucose tolerance test. Homeostasis Model Assessment Insulin resistance index (HOMA-IR) and Quantitative Insulin Sensitivity Check Index (QUICKI) and glucose intolerance was calculated. FG score, LH, FSH, total Testosterone, HOMA-IR and QUICKI were significantly different among women with or without PCOS (p < 0.01). Although hs-CRP levels showed a higher trend in women having PCOS, there was no significant difference between the groups (p > 0.05). A significant and positive correlation was found between hs-CRP and body mass index (BMI) (r = 0.308, p < 0.01) among PCOS group. The results in Indian adolescent women suggest that hs-CRP levels may not per se be associated with PCOS, rather can be related to fat mass in this subset of subjects.C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are available on high-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of PCOS especially in Indian women. The objective was to determine serum hs-CRP concentration in adolescent women with and without PCOS and to assess possible correlations of serum hs-CRP levels with components of PCOS in Indian women. One hundred and sixty women with PCOS and sixty non-PCOS women having normal menstrual cycles were included. Clinical assessment included anthropometry, Ferriman-Gallwey (FG) score and blood pressure (BP) measurement. Laboratory evaluation included estimation of T4, TSH, LH, FSH, total testosterone, prolactin, cortisol, 17OHP, hs-CRP, lipid profile, and insulin, and glucose after 2-h oral glucose tolerance test. Homeostasis Model Assessment Insulin resistance index (HOMA-IR) and Quantitative Insulin Sensitivity Check Index (QUICKI) and glucose intolerance was calculated. FG score, LH, FSH, total Testosterone, HOMA-IR and QUICKI were significantly different among women with or without PCOS (p < 0.01). Although hs-CRP levels showed a higher trend in women having PCOS, there was no significant difference between the groups (p > 0.05). A significant and positive correlation was found between hs-CRP and body mass index (BMI) (r = 0.308, p < 0.01) among PCOS group. The results in Indian adolescent women suggest that hs-CRP levels may not per se be associated with PCOS, rather can be related to fat mass in this subset of subjects.
C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are available on high-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of PCOS especially in Indian women. The objective was to determine serum hs-CRP concentration in adolescent women with and without PCOS and to assess possible correlations of serum hs-CRP levels with components of PCOS in Indian women. One hundred and sixty women with PCOS and sixty non-PCOS women having normal menstrual cycles were included. Clinical assessment included anthropometry, Ferriman-Gallwey (FG) score and blood pressure (BP) measurement. Laboratory evaluation included estimation of T4, TSH, LH, FSH, total testosterone, prolactin, cortisol, 17OHP, hs-CRP, lipid profile, and insulin, and glucose after 2-h oral glucose tolerance test. Homeostasis Model Assessment Insulin resistance index (HOMA-IR) and Quantitative Insulin Sensitivity Check Index (QUICKI) and glucose intolerance was calculated. FG score, LH, FSH, total Testosterone, HOMA-IR and QUICKI were significantly different among women with or without PCOS (p < 0.01). Although hs-CRP levels showed a higher trend in women having PCOS, there was no significant difference between the groups (p > 0.05). A significant and positive correlation was found between hs-CRP and body mass index (BMI) (r = 0.308, p < 0.01) among PCOS group. The results in Indian adolescent women suggest that hs-CRP levels may not per se be associated with PCOS, rather can be related to fat mass in this subset of subjects.
Abstract C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are available on high-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of PCOS especially in Indian women. The objective was to determine serum hs-CRP concentration in adolescent women with and without PCOS and to assess possible correlations of serum hs-CRP levels with components of PCOS in Indian women. One hundred and sixty women with PCOS and sixty non-PCOS women having normal menstrual cycles were included. Clinical assessment included anthropometry, Ferriman-Gallwey (FG) score and blood pressure (BP) measurement. Laboratory evaluation included estimation of T4, TSH, LH, FSH, total testosterone, prolactin, cortisol, 17OHP, hs-CRP, lipid profile, and insulin, and glucose after 2-h oral glucose tolerance test. Homeostasis Model Assessment Insulin resistance index (HOMA-IR) and Quantitative Insulin Sensitivity Check Index (QUICKI) and glucose intolerance was calculated. FG score, LH, FSH, total Testosterone, HOMA-IR and QUICKI were significantly different among women with or without PCOS (p < 0.01). Although hs-CRP levels showed a higher trend in women having PCOS, there was no significant difference between the groups (p > 0.05). A significant and positive correlation was found between hs-CRP and body mass index (BMI) (r = 0.308, p < 0.01) among PCOS group. The results in Indian adolescent women suggest that hs-CRP levels may not per se be associated with PCOS, rather can be related to fat mass in this subset of subjects. Chinese abstract C反应蛋白(CRP)是2型糖尿病和心血管疾病的危险因素。对于多囊卵巢综合征(PCOS),尤其是印度女性,在高敏C反应蛋白(hs-CRP)水平及其与PCOS的各项组分的关系方面,可查到的数据很有限。本研究的目的是监测患或不患PCOS的青春期女性的血清hs-CRP浓度,评估印度女性的血清hs-CRP浓度与PCOS指标间可能的相关性。160名PCOS患者和60名有正常月经周期的非PCOS女性参与了本试验。临床评价包括人体测量,Ferriman-Gallwey(FG)评分和血压(BP)测量。实验室测定指标包括T4,TSH, LH,,FSH,总睾酮,催乳素,皮质醇,17-OHP,hs-CRP,血脂,胰岛素的测量和2h口服葡萄糖耐量试验。同时测量稳态模式评估胰岛素抵抗指数(HOMA-IR),定量胰岛素敏感性检测指数(QUICKI)以及葡萄糖耐量。PCOS患者与正常女性的FG得分,LH,,FSH,HOMA-IR,QUICKI存在显著不同(p<0.01),尽管PCOS患者的hs-CRP水平有增高的趋势,但两组并无显著差别(p>0.05)。在PCOS组还发现hs-CRP与体重指数(BMI)有显著正相关(r=0.308, p<0.01)。该结果表明,hs-CRP水平与PCOS也许无关联性,而可能与该课题中的子项目即体重相关。
Author Douhat, Syed
Nisar, Sobia
Rashid, Aafia
Ahmed, Ishfaq
Mudassar, Syed
Ganie, Mohd Ashraf
Jan, Vicar M.
Rashid, Fouzia
Shamas, Nasir
Hassan, Saqib
Author_xml – sequence: 1
  givenname: Mohd Ashraf
  surname: Ganie
  fullname: Ganie, Mohd Ashraf
  email: ashraf.endo@gmail.com, ashraf.endo@gmail.com
  organization: Department of Endocrinology and Metabolism, All India Institute of Medical Sciences
– sequence: 2
  givenname: Saqib
  surname: Hassan
  fullname: Hassan, Saqib
  email: ashraf.endo@gmail.com, ashraf.endo@gmail.com
  organization: Department of Endocrinology, Sheri-Kashmir Institute of Medical Sciences
– sequence: 3
  givenname: Sobia
  surname: Nisar
  fullname: Nisar, Sobia
  email: ashraf.endo@gmail.com, ashraf.endo@gmail.com
  organization: Departments of Geriatric Medicine, All India of Medical Sciences
– sequence: 4
  givenname: Nasir
  surname: Shamas
  fullname: Shamas, Nasir
  email: ashraf.endo@gmail.com, ashraf.endo@gmail.com
  organization: Department of Endocrinology, Sheri-Kashmir Institute of Medical Sciences
– sequence: 5
  givenname: Aafia
  surname: Rashid
  fullname: Rashid, Aafia
  email: ashraf.endo@gmail.com, ashraf.endo@gmail.com
  organization: Department of Endocrinology, Sheri-Kashmir Institute of Medical Sciences
– sequence: 6
  givenname: Ishfaq
  surname: Ahmed
  fullname: Ahmed, Ishfaq
  email: ashraf.endo@gmail.com, ashraf.endo@gmail.com
  organization: Department of Endocrinology, Sheri-Kashmir Institute of Medical Sciences
– sequence: 7
  givenname: Syed
  surname: Douhat
  fullname: Douhat, Syed
  email: ashraf.endo@gmail.com, ashraf.endo@gmail.com
  organization: Department of Endocrinology, Sheri-Kashmir Institute of Medical Sciences
– sequence: 8
  givenname: Syed
  surname: Mudassar
  fullname: Mudassar, Syed
  email: ashraf.endo@gmail.com, ashraf.endo@gmail.com
  organization: Department of Clinical Biochemistry, Sheri-Kashmir Institute of Medical Sciences
– sequence: 9
  givenname: Vicar M.
  surname: Jan
  fullname: Jan, Vicar M.
  email: ashraf.endo@gmail.com, ashraf.endo@gmail.com
  organization: Department of Cardiology, Sheri-Kashmir Institute of Medical Sciences
– sequence: 10
  givenname: Fouzia
  surname: Rashid
  fullname: Rashid, Fouzia
  email: ashraf.endo@gmail.com, ashraf.endo@gmail.com
  organization: Department of Clinical Biochemistry, University of Kashmir
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25137507$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1DAUhS1URKeFN0DIy-kigx07icMChCJKK1Vqxc_aupM4xJVjB9szo7wYz1cP01mARFlZV_d8R9fnnKET66xC6DUlK0ZJ_ZbUBWVFTVY5oXxV55zU9TO0oLxiGanK8gQt9pJsrzlFZyHcE0IZr_IX6DRPaFWQaoF-XekfQxaUDTrqrY4zbjKvoE2DwpN3UWmLl0PImi93F9iorTIBg-2wjgF7ZSBqZ8OgJ7zTccCtG6d0pk1L1-PJmbmdQ9QtdlvwMw6z7bwbFU6m17bTYDF0zqjQJgTv0sYefP5NLu-a268XL9HzHkxQrx7fc_T98tO35iq7uf183Xy8yVpORcygE3nB1n0vWMfKdVmmoRAgGEm_F1D0gpeEsIJCLghjnOTAAARdcybqvOLsHC0PvimKnxsVohx1OtYYsMptgqQlLXlVUSaS9M2jdLMeVScnr8d0uTxmnQTvDoLWuxC86mWr4-_8ogdtJCVyX6w8Fiv3xcpDsQnmf8FH__9gHw6Ytr3zI-ycN52MMBvnew-21WFPP-nw_g-HQYGJQwteyXu38Tal__QJD4Ppzsc
CitedBy_id crossref_primary_10_1016_j_fertnstert_2020_02_001
crossref_primary_10_1097_MD_0000000000032326
crossref_primary_10_3390_biomedicines11071953
crossref_primary_10_1016_j_fertnstert_2015_09_005
crossref_primary_10_1002_edm2_477
crossref_primary_10_21763_tjfmpc_359835
crossref_primary_10_1007_s40618_016_0582_x
crossref_primary_10_1038_s41598_019_40653_z
crossref_primary_10_1007_s12291_023_01115_6
crossref_primary_10_20945_2359_3997000000497
crossref_primary_10_1002_ijgo_13125
crossref_primary_10_3109_09513590_2016_1141879
crossref_primary_10_1016_j_psj_2023_102820
crossref_primary_10_31832_smj_855493
crossref_primary_10_2217_bmm_2018_0271
crossref_primary_10_1177_2050313X19843737
crossref_primary_10_1007_s43032_021_00662_8
crossref_primary_10_2147_JIR_S313193
crossref_primary_10_1016_j_jpag_2016_03_004
Cites_doi 10.2337/dc08-1795
10.1210/jc.2007-0334
10.1161/01.CIR.102.1.42
10.1016/j.jpag.2011.03.002
10.1210/jc.2003-031096
10.1210/jcem.86.6.7580
10.1093/clinchem/36.2.283
10.1530/eje.0.1500525
10.1093/humupd/dmr025
10.1155/2009/465203
10.2337/diab.38.9.1165
10.1186/1741-7015-8-41
10.1016/S0002-9378(15)30642-6
10.1016/j.mce.2010.08.002
10.1080/09513590701554306
10.1056/NEJM200003233421202
10.1161/01.CIR.0000089191.72957.ED
10.1093/humupd/dmg044
10.3109/09513590.2011.613967
10.1530/EJE-09-0379
10.1210/jc.2009-2724
10.1210/jc.2006-0178
10.1161/01.CIR.0000053730.47739.3C
10.1038/nrendo.2010.217
10.3904/kjim.2009.24.4.350
10.1210/jc.2003-032046
10.4103/2230-8210.95680
10.4103/2230-8210.103021
ContentType Journal Article
Copyright 2014 Informa UK Ltd. All rights reserved: reproduction in whole or part not permitted 2014
Copyright_xml – notice: 2014 Informa UK Ltd. All rights reserved: reproduction in whole or part not permitted 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.3109/09513590.2014.924099
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1473-0766
EndPage 784
ExternalDocumentID 25137507
10_3109_09513590_2014_924099
924099
Genre Research Article
Journal Article
Observational Study
GeographicLocations India
GeographicLocations_xml – name: India
GroupedDBID ---
00X
03L
0BK
0R~
0YH
29I
36B
3V.
4.4
53G
5GY
5VS
7X7
88E
8AO
8FI
8FJ
AAJNR
AALIY
AALUX
AAMIU
AAPUL
AAPXX
AAQRR
ABBKH
ABDBF
ABEIZ
ABLKL
ABPTK
ABUPF
ABUWG
ABWCV
ABZEW
ACENM
ACFUF
ACGEJ
ACGFO
ACGFS
ACKZS
ACLSK
ADBBV
ADCVX
ADFCX
ADFOM
ADFZZ
ADRBQ
ADXPE
AECIN
AEGXH
AEIIZ
AENEX
AEOZL
AEYQI
AFKRA
AFKVX
AFLEI
AFWLO
AGDLA
AGFJD
AGRBW
AHMBA
AIAGR
AIJEM
AIRBT
AJVHN
AJWEG
AKBVH
ALIIL
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AMDAE
AWYRJ
BABNJ
BENPR
BLEHA
BOHLJ
BPHCQ
BRMBE
BVXVI
CAG
CCCUG
COF
CS3
CYYVM
CZDIS
DKSSO
DRXRE
DU5
DWTOO
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
FYUFA
H13
HZ~
IPNFZ
JENTW
KRBQP
KSSTO
KWAYT
KYCEM
LGLTD
LJTGL
M1P
M44
M4Z
O9-
P2P
PQEST
PQQKQ
PQUKI
PROAC
PSQYO
QQXMO
RIG
RNANH
RRB
RVRKI
RWL
S0X
SV3
TAE
TFDNU
TFL
TFW
TUS
UEQFS
UKHRP
V1S
~1N
ABJNI
ABLIJ
ABXYU
ACUHS
AGYJP
ALIPV
ALYBC
TBQAZ
TDBHL
TERGH
TUROJ
AAFWJ
AAGDL
AAORF
AAYXX
ABWVI
ACOPL
ACYZI
ADYSH
AFPKN
AFRVT
CCPQU
CITATION
GROUPED_DOAJ
HMCUK
NUSFT
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c418t-ad8253bff83d36b6653b58a8307508a5f84600351a28033402a3aa81b43892743
ISSN 0951-3590
1473-0766
IngestDate Thu Sep 04 17:21:02 EDT 2025
Thu Apr 03 07:01:25 EDT 2025
Thu Apr 24 23:01:24 EDT 2025
Tue Jul 01 00:23:11 EDT 2025
Wed Dec 25 09:04:53 EST 2024
Wed Jun 21 08:14:53 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Body mass index
HOMA-IR
hs C-reactive protein
testosterone
insulin resistance
Ferriman–Gallwey score
obesity
polycystic ovary syndrome
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c418t-ad8253bff83d36b6653b58a8307508a5f84600351a28033402a3aa81b43892743
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
PMID 25137507
PQID 1616477138
PQPubID 23479
PageCount 4
ParticipantIDs crossref_citationtrail_10_3109_09513590_2014_924099
crossref_primary_10_3109_09513590_2014_924099
informaworld_taylorfrancis_310_3109_09513590_2014_924099
proquest_miscellaneous_1616477138
pubmed_primary_25137507
informahealthcare_journals_10_3109_09513590_2014_924099
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20141100
11/1/2014
2014-11-00
2014-Nov
20141101
PublicationDateYYYYMMDD 2014-11-01
PublicationDate_xml – month: 11
  year: 2014
  text: 20141100
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Gynecological endocrinology
PublicationTitleAlternate Gynecol Endocrinol
PublicationYear 2014
Publisher Informa UK Ltd
Taylor & Francis
Publisher_xml – name: Informa UK Ltd
– name: Taylor & Francis
References Oh JY (CIT0021) 2009; 24
Gill H (CIT0003) 2012; 16
CIT0012
Capoglu I (CIT0023) 2009; 4
Boulman N (CIT0016) 2004; 89
Tosi F (CIT0025) 2009; 161
Azziz R (CIT0001) 2004; 89
Guzelmeric K (CIT0019) 2007; 23
Dunaif A (CIT0011) 1989; 38
Azziz R (CIT0026) 2006; 91
CIT0018
CIT0017
Festa A (CIT0028) 2000; 102
Balen AH (CIT0027) 2003; 9
Ferrannini E (CIT0029) 2007; 92
Ridker PM (CIT0013) 2000; 342
Wild RA (CIT0010) 1990; 36
CIT0020
de Rooij SR (CIT0030) 2009; 32
Teede H (CIT0007) 2010; 8
Verma S (CIT0015) 2003; 108
Kim JW (CIT0024) 2012; 28
Ridker PM (CIT0014) 2003; 107
Legro RS (CIT0005) 1999; 84
CIT0002
CIT0004
CIT0006
CIT0009
CIT0008
Karoli R (CIT0022) 2012; 16
References_xml – volume: 32
  start-page: 1295
  year: 2009
  ident: CIT0030
  publication-title: Diabetes Care
  doi: 10.2337/dc08-1795
– volume: 92
  start-page: 2885
  year: 2007
  ident: CIT0029
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-0334
– volume: 102
  start-page: 42
  year: 2000
  ident: CIT0028
  publication-title: Circulation
  doi: 10.1161/01.CIR.102.1.42
– ident: CIT0002
  doi: 10.1016/j.jpag.2011.03.002
– volume: 89
  start-page: 2160
  year: 2004
  ident: CIT0016
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2003-031096
– ident: CIT0012
  doi: 10.1210/jcem.86.6.7580
– volume: 36
  start-page: 283
  year: 1990
  ident: CIT0010
  publication-title: Clin Chem
  doi: 10.1093/clinchem/36.2.283
– ident: CIT0017
  doi: 10.1530/eje.0.1500525
– ident: CIT0020
  doi: 10.1093/humupd/dmr025
– ident: CIT0018
  doi: 10.1155/2009/465203
– volume: 38
  start-page: 1165
  year: 1989
  ident: CIT0011
  publication-title: Diabetes
  doi: 10.2337/diab.38.9.1165
– volume: 8
  start-page: 41
  year: 2010
  ident: CIT0007
  publication-title: BMC Med
  doi: 10.1186/1741-7015-8-41
– ident: CIT0006
  doi: 10.1016/S0002-9378(15)30642-6
– ident: CIT0009
  doi: 10.1016/j.mce.2010.08.002
– volume: 23
  start-page: 505
  year: 2007
  ident: CIT0019
  publication-title: Gynecol Endocrinol
  doi: 10.1080/09513590701554306
– volume: 84
  start-page: 165
  year: 1999
  ident: CIT0005
  publication-title: J Clin Endocrinol Metab
– volume: 342
  start-page: 836
  year: 2000
  ident: CIT0013
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200003233421202
– volume: 108
  start-page: 2054
  year: 2003
  ident: CIT0015
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000089191.72957.ED
– volume: 9
  start-page: 505
  year: 2003
  ident: CIT0027
  publication-title: Hum Reprod Update
  doi: 10.1093/humupd/dmg044
– volume: 28
  start-page: 259
  year: 2012
  ident: CIT0024
  publication-title: Gynecol Endocrinol
  doi: 10.3109/09513590.2011.613967
– volume: 161
  start-page: 737
  year: 2009
  ident: CIT0025
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-09-0379
– ident: CIT0008
  doi: 10.1210/jc.2009-2724
– volume: 91
  start-page: 4237
  year: 2006
  ident: CIT0026
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2006-0178
– volume: 4
  start-page: 428
  year: 2009
  ident: CIT0023
  publication-title: Cent Eur J Med
– volume: 107
  start-page: 363
  year: 2003
  ident: CIT0014
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000053730.47739.3C
– ident: CIT0004
  doi: 10.1038/nrendo.2010.217
– volume: 24
  start-page: 350
  year: 2009
  ident: CIT0021
  publication-title: Korean J Intern Med
  doi: 10.3904/kjim.2009.24.4.350
– volume: 89
  start-page: 2745
  year: 2004
  ident: CIT0001
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2003-032046
– volume: 16
  start-page: 389
  year: 2012
  ident: CIT0003
  publication-title: Indian J Endocr Metab
  doi: 10.4103/2230-8210.95680
– volume: 16
  start-page: 1004
  year: 2012
  ident: CIT0022
  publication-title: Indian J Endocrinol Metab
  doi: 10.4103/2230-8210.103021
SSID ssj0013472
Score 2.168394
Snippet Abstract C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data...
C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are...
SourceID proquest
pubmed
crossref
informaworld
informahealthcare
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 781
SubjectTerms Adolescent
Adult
Blood Glucose - metabolism
Body Mass Index
C-Reactive Protein - metabolism
Cardiovascular Diseases - blood
Cardiovascular Diseases - etiology
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - etiology
Female
Ferriman-Gallwey score
Follicle Stimulating Hormone - blood
Glucose Tolerance Test
HOMA-IR
hs C-reactive protein
Humans
India
Insulin - blood
insulin resistance
Insulin Resistance - physiology
Lipids - blood
Luteinizing Hormone - blood
obesity
Obesity - blood
polycystic ovary syndrome
Polycystic Ovary Syndrome - blood
Polycystic Ovary Syndrome - complications
Risk Factors
testosterone
Testosterone - blood
Thyroid Hormones - blood
Young Adult
Title High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS)
URI https://www.tandfonline.com/doi/abs/10.3109/09513590.2014.924099
https://www.ncbi.nlm.nih.gov/pubmed/25137507
https://www.proquest.com/docview/1616477138
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FVkJcUHk2vLRIHFpVW2zv-pFjG2gLEqUirdSbtV7bSqTUDnGCFH4Yf44LM971I6FpKRcrsbLjx3yZnZn9doaQd17qutJOXZZwzplQImI9J4lYYsfKs5TqKV3t89Q7uRCfL93LTud3i7U0n0X76ue1-0r-R6twDvSKu2TvoNlaKJyAz6BfOIKG4fhPOkaSBiuQgm56QPQZ-IClBdsrCzCMULXBsGD9b2cY_4-RIlS0FgwMEw4ZW4aEfjXJs8RwYyb5eKEWWMl5L_-B9LqqvgFmST5lZVWDpiSUruag5awfCfdz1v86qDIQxi8-XmSJqu1wksU5WLPllP8xboYv87f5MAZYDacybexnUZhMrvw-ilqLLZo_PsijUT3_DIbySm9jO5XFaNrOe9jCbABsJzBtxl3dbHQ_0eZb-JxZvu7jUtl3s-5jcGy3rLWvu8WYid_XvepW5xSuS7Li5fBqyAYU-xC1Wrqx03IJ75WptSY8QqiFcsJKSohSQi3lHtl0fB85BpsHhx8Oj5pFMFH2HqsfVO_8RDnvr7ubJc9qy9TdHdYswpVavOsjqtKzOt8iD01IRA80vh-RTpI9Jve_GNLHE_JrFea0gTk1MKc7GuS7VEOcAsQpQJy2IU4RmrSBOM1T2gCVlkClFVApCNUQpw3EaQlxLWf9yB0E-O5TcnH08bx_wky7EaaEHcyYjAPH5VGaBjzmXuR58MUNZMDRqw6km4KrXi68S-zoxoXlSC4lhH0CnH4HPPFnZCOD-98mNHUs1bOEnaZuLGK7F1lClb6061pp7CVdwitVhcrU4seWMOPwJqB0CatHTXQtmlt-7_-FgtCYr-KWkUEbK-GszB6mutUPDrtp6NsKVyHMVLj8KLMkn8MFPaxd6Ns86JLnGnD1Y0CUxeEt-y_u-IgvyYPGNrwiG7PpPHkNUcIsemP-TX8A79kNhg
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High-sensitivity+C-reactive+protein+%28hs-CRP%29+levels+and+its+relationship+with+components+of+polycystic+ovary+syndrome+in+Indian+adolescent+women+with+polycystic+ovary+syndrome+%28PCOS%29&rft.jtitle=Gynecological+endocrinology&rft.au=Ganie%2C+Mohd+Ashraf&rft.au=Hassan%2C+Saqib&rft.au=Nisar%2C+Sobia&rft.au=Shamas%2C+Nasir&rft.date=2014-11-01&rft.issn=0951-3590&rft.eissn=1473-0766&rft.volume=30&rft.issue=11&rft.spage=781&rft.epage=784&rft_id=info:doi/10.3109%2F09513590.2014.924099&rft.externalDBID=n%2Fa&rft.externalDocID=10_3109_09513590_2014_924099
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0951-3590&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0951-3590&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0951-3590&client=summon